Immunomodulatory extracellular vesicles: an alternative to cell therapy for COVID-19

References

• Börger V, Weiss DJ, Anderson JD, et al. International society for extracellular vesicles and international society for cell and gene therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations for potential therapeutic agents to suppress coronavirus disease-19. Cytotherapy. 2020;22(9):482–485.
   PubMed Web of Science ®Google Scholar
• COVID-19 dashboard by the center for systems science and Engineering (CSSE) at Johns Hopkins University (JHU). [cited 2020 Nov 20]. Available from: https://coronavirus.jhu.edu/map.html
   Google Scholar
• WHO Coronavirus Disease (COVID-19) Dashboard, WHO/World Heal. Organ. (2020). [cited 2020 Nov 20]. Available from: https://covid19.who.int
   Google Scholar
• Luceri F, Morelli I, Accretta R, et al. Italy and COVID-19: the changing patient flow in an orthopedic trauma center emergency department. J Orthop Surg Res. 2020;15(1):323.
   PubMed Web of Science ®Google Scholar
• Morelli I, Luceri F, Giorgino R, et al. COVID-19: not a contraindication for surgery in patients with proximal femur fragility fractures. J Orthop Surg Res. 2020;15(1):285.
   PubMed Web of Science ®Google Scholar
• Cipollaro L, Giordano L, Padulo J, et al. Musculoskeletal symptoms in SARS-CoV-2 (COVID-19) patients. J Orthop Surg Res. 2020;15(1):178.
   PubMed Web of Science ®Google Scholar
• de Girolamo L, Peretti G, Maffulli N, et al. Covid-19—The real role of NSAIDs in Italy. J Orthop Surg Res. 2020;15(1):165.
   PubMed Web of Science ®Google Scholar
• Zhao RC. Stem cell-based therapy for coronavirus disease 2019. Stem Cells Dev. 2020;29(11):679–681.
   PubMed Web of Science ®Google Scholar
• Leng Z, Zhu R, Hou W, et al. Transplantation of ACE2− mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. 2020;11(2):216–228.
   PubMed Web of Science ®Google Scholar
• Rodriguez HC, Gupta M, Cavazos-Escobar E, et al. Umbilical cord: an allogenic tissue for potential treatment of COVID-19. Hum Cell. 2020;34(1):1–13.
   PubMed Web of Science ®Google Scholar
• Machhi J, Herskovitz J, Senan AM, et al. The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. J Neuroimmune Pharmacol. 2020;15(3):359–386.
   PubMed Web of Science ®Google Scholar
• Gupta A, Kashte S, Gupta M, et al. Mesenchymal stem cells and exosome therapy for COVID‑19 : current status and future perspective. Hum Cell. 2020;33(4):907–918.
   PubMed Web of Science ®Google Scholar
• Mangalmurti N, Hunter CA. Cytokine storms : understanding COVID-19. Immunity. 2020;53(1):19–25.
   PubMed Web of Science ®Google Scholar
• Hossein G, Zohreh M, Hedayat J, et al. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging.” Inflamm. Res. 2020; 69(9): 825-839.
   Google Scholar
• Xiao K, Hou F, Huang X, et al. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19. Stem Cell Res Ther. 2020;11(1):305.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Xingwang L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;396(10223):497–506.
   Google Scholar
• Sleem A, Saleh F. Mesenchymal stem cells in the fight against viruses: face to face with the invisible enemy. Curr Res Transl Med. [Internet]. Elsevier Masson SAS. 2020;68(3):105–110.
   PubMed Web of Science ®Google Scholar
• Sanders J, Monogue ML, Jodlowski TZ, et al. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;323(18):1824–1836.
   PubMed Web of Science ®Google Scholar
• Murthy S, Gomersall CD, Fowler RA. Care for critically ill patients with COVID-19. JAMA. 2020;323(15):1499–1500.
   PubMed Web of Science ®Google Scholar
• Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020;323(20):2052–2059.
   PubMed Web of Science ®Google Scholar
• Kashte S, Maras JS, Kadam S. Bioinspired engineering for liver tissue regeneration and development of bioartificial liver: a review. Crit Rev Biomed Eng. 2018;46(5):413–427.
   PubMedGoogle Scholar
• Kashte S, Kadam S. Stem cell therapy : a hope business or a magic wand? Br. Biomed Bull. 2014;2:677–694.
   Google Scholar
• Potty AGR, Gupta A, Rodriguez HC, et al. Intraosseous bioplasty for a subchondral cyst in the lateral condyle of femur. J Clin Med. 2020;9(5):1358.
   Web of Science ®Google Scholar
• Yun JW, Ahn JH, Kwon E, et al. Human umbilical cord-derived mesenchymal stem cells in acute liver injury: hepatoprotective efficacy, subchronic toxicity, tumorigenicity, and biodistribution. Regul Toxicol Pharmacol. 2016;81:437–447.
   PubMed Web of Science ®Google Scholar
• Matthay MA, Calfee CS, Zhuo H, et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial. Lancet Respir Med. 2019;7(2):154–162.
   PubMed Web of Science ®Google Scholar
• Wilson JG, Liu KD, Zhuo H, et al. Mesenchymal stem (stromal) cells for treatment of ARDS : a phase 1 clinical trial. Lancet Respir Med. 2015;3(1):24–32.
   PubMed Web of Science ®Google Scholar
• Rawat S, Gupta S, Mohanty S. Mesenchymal stem cells modulate the immune system in developing therapeutic interventions. IntechOpen. 2019;1–25. DOI: https://doi.org/10.5772/intechopen.80772.
   Google Scholar
• Paliwal S, Chaudhuri R, Agrawal A, et al. Regenerative abilities of mesenchymal stem cells through mitochondrial transfer. J Biomed Sci. 2018;25(1):1–12.
   PubMedGoogle Scholar
• Liang B, Chen J, Li T, et al. Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells. chinaXiv. Internet. 2020;2:v1. Available from: chinaXiv.
   Google Scholar
• Gattinoni L, Coppola S, Cressoni M, et al. COVID-19 does not lead to a “typical” acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201(10):1299–1300.
   PubMed Web of Science ®Google Scholar
• Mendt M, Rezyani K, Shpall E. Mesenchymal stem cell-derived exosomes for clinical use. Bone Marrow Transplant. 2019;54(Suppl 2):789–792.
   PubMed Web of Science ®Google Scholar
• Wang S, Guo L, Jianfeng G, et al. Excess integrins cause lung entrapment of mesenchymal stem cells. Stem Cells. 2015;33(11):3315–3326.
   PubMed Web of Science ®Google Scholar
• Jeong JO, Han JW, Kim JM, et al. Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ Res. 2011;108(11): 1349–7. doi:https://doi.org/10.1161/CIRCRESAHA.110.239848.
   Google Scholar
• Gupta A, Cady C, Fauser AM, et al. Cell - free stem cell-derived extract formulation for regenerative medicine applications. Int J Mol Sci. 2020;21(24):E9364.
   PubMed Web of Science ®Google Scholar
• Witwer KW, Théry C. Extracellular vesicles or exosomes? On primacy, precision, and popularity influencing a choice of nomenclature. J Extracell Vesicles [Internet]. Taylor & Francis; 2019;8(1):1648167. Available from:
   PubMed Web of Science ®Google Scholar
• Théry C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1): 1535750.
   Web of Science ®Google Scholar
• Harding CV, Heuser JE, Stahl PD. Exosomes : looking back three decades and into the future. J Cell Biol. 2013;200(4):367–371.
   PubMed Web of Science ®Google Scholar
• Li J, Wei L, Han Z, et al. Mesenchymal stromal cells-derived exosomes alleviate ischemia/reperfusion injury in mouse lung by transporting anti-apoptotic miR-21-5p. Eur J. 2019;852:68-76.
   Google Scholar
• Zhao AG, Shah K, Cromer B, et al. Review article mesenchymal stem cell-derived extracellular vesicles and their therapeutic potential. Stem Cells Int. 2020;2020:8825771.
   PubMedGoogle Scholar
• Ellwanger JH, Veit TD, Artur J, et al. Exosomes in HIV infection: a review and critical look. Infect Genet Evol. [Internet]. Elsevier B.V. 2017:1–33. Available from. DOI:https://doi.org/10.1016/j.meegid.2017.05.021.
   Google Scholar
• Jabbari N, Akbariazar E, Feqhhi M, et al. Breast cancer-derived exosomes: tumor progression and therapeutic agents. J Cell Physiol. 2020;235(10):6345–6356.
   PubMed Web of Science ®Google Scholar
• Toh WEIS, Zhang BIN, Lai RC, et al. Immune regulatory targets of mesenchymal stromal cell exosomes/small extracellular vesicles in tissue regeneration. Cytotherapy. [Internet]. Elsevier Inc. 2018;20(12):1419–1426.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Liu H, et al. Exosomes : biogenesis, biologic function and clinical potential. Cell Biosci. [Internet]. BioMed Central. 2019;9(1):9–19.
   PubMedGoogle Scholar
• Huang-doran I, Zhang C, Vidal-puig A. Extracellular vesicles : novel mediators of cell communication in metabolic disease. Trends Endocrinol Metab. [Internet]. Elsevier Ltd. 2016;28(1):3–18.
   PubMed Web of Science ®Google Scholar
• Cheng L, Zhang K, Wu S, et al. Focus on mesenchymal stem cell-derived exosomes : opportunities and challenges in cell-free therapy. Stem Cells Int. Hindawi. 2017;2017:1–10.
   Web of Science ®Google Scholar
• Jabbari N, Karimipour M, Khaksar M, et al. Tumor-derived extracellular vesicles: insights into bystander effects of exosomes after irradiation. Lasers Med Sci. 2020;35(3):531–545.
   PubMed Web of Science ®Google Scholar
• Wang M, Yuan Q, Xie L. Review article mesenchymal stem cell-based immunomodulation : properties and clinical application. Stem Cells Int. 2018;2018:12.
   Web of Science ®Google Scholar
• Ahmadi M, Rezaie J. Tumor cells derived - exosomes as angiogenic agents: possible therapeutic implications. J Transl Med. 2020;18(1):249.
   PubMed Web of Science ®Google Scholar
• Xu S, Liu C, Ji HL. Concise review : therapeutic potential of the mesenchymal stem cell derived secretome and extracellular vesicles for radiation-induced lung injury : progress and hypotheses. Stem Cells Transl Med. 2019;8(4):344–354.
   PubMed Web of Science ®Google Scholar
• Giai Via A, McCarthy MB, de Girolamo L, et al. Making them commit: strategies to influence phenotypic differentiation in mesenchymal stem cells. Sports Med Arthrosc Rev. 2018;26(2):64–69.
   PubMed Web of Science ®Google Scholar
• Ciardulli MC, Marino L, Lamparelli EP, et al. Dose-response tendon-specific markers induction by growth differentiation factor-5 in human bone marrow and umbilical cord mesenchymal stem cells. Int J Mol Sci. 2020;21(16):5905.
   Web of Science ®Google Scholar
• Govoni M, Berardi AC, Muscari C, et al. An engineered multiphase three-dimensional microenvironment to ensure the controlled delivery of cyclic strain and human growth differentiation factor 5 for the tenogenic commitment of human bone marrow mesenchymal stem cells. Tissue Eng Part A. 2017;23(15–16):811–822.
   PubMed Web of Science ®Google Scholar
• Lee JH, Park J, Lee J. Therapeutic use of mesenchymal stem cell-derived extracellular vesicles in acute lung injury Jae. Transfusion. 2019;59(S1):876–883.
   PubMedGoogle Scholar
• Monsel A, Zhu Y, Gudapati V, et al. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases. Expert Opin Biol Ther. 2017;16(7):859–871.
   Web of Science ®Google Scholar
• Melzer C, von der Ohe J, Hass R, et al. Talk with cancer cells provides therapeutic potential. Stem Cells. 2018;36(7):951–968.
   PubMed Web of Science ®Google Scholar
• Natasha G, Gundogan B, Tan A, et al. Exosomes as immunotheranostic nanoparticles. Clin Ther. [ [Internet]. Elsevier]. 2014;36(6):1–10. Available from.
   PubMed Web of Science ®Google Scholar
• Baglio SR, Pegtel DM, Baldini N. Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol. 2012;3:1–11.
   PubMed Web of Science ®Google Scholar
• Reiner A, Witwer KW, van Balkom BWM, et al. Concise review: developing best-practice models for the therapeutic use of extracellular vesicles. Stem Cells Transl Med. 2017;6(8):1730–1739.
   PubMed Web of Science ®Google Scholar
• Whittaker TE, Nagelkerke A, Nele V, et al. Experimental artefacts can lead to misattribution of bioactivity from soluble mesenchymal stem cell paracrine factors to extracellular vesicles. J Extracell Vesicles. 2020;9(1):1807674.
   PubMed Web of Science ®Google Scholar
• Witwer KW, Van Balkom BWM, Bruno S, et al. Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications. J Extracell Vesicels. 2019;8(1):1609206.
   PubMed Web of Science ®Google Scholar
• Klara H, Simpson RJ, Ji H, et al. Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol. 2012;10(12):e1001450.
   PubMed Web of Science ®Google Scholar
• Qian X, Xu C, Fang S, et al. Exosomal microRNAs derived from umbilical mesenchymal stem cells inhibit hepatitis C virus infection. Stem Cells Transl Med. 2016;5(9):1190–1203.
   PubMed Web of Science ®Google Scholar
• Khatri M, Richardson LA, Meulia T. Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model. Stem Cell Res Ther. 2018;9(1):1–13.
   PubMedGoogle Scholar
• Sun L, Wang X, Zhou Y, et al. Exosomes contribute to the transmission of anti-HIV activity from TLR3-activated brain microvascular endothelial cells to macrophages. Antiviral Res. [Internet]. Elsevier Ltd. 2016;134:167–171. Available from: .
   Web of Science ®Google Scholar
• Tumne A, Prasad VS, Chen Y, et al. Noncytotoxic suppression of human immunodeficiency virus type 1 transcription by exosomes secreted from CD8+ T cells. J Virol. 2009;83(9):4354–4364.
   PubMed Web of Science ®Google Scholar
• Naslund TI, Paquin-Proulx D, Paredes PT, et al. Exosomes from breast milk inhibit HIV-1 infection of dendritic cells and subsequent viral transfer to CD4+ T cells. Aids. 2014;28(2):171.
   PubMed Web of Science ®Google Scholar
• Madison MN, Jones PH, Okeoma CM. Exosomes in human semen restrict HIV-1 transmission by vaginal cells and block intravaginal replication of LP-BM5 murine AIDS virus complex. Virology. Elsevier Inc. 2015;482:189–201.
   PubMed Web of Science ®Google Scholar
• Smith JA, Daniel R. Human vaginal fluid contains exosomes that have an inhibitory effect on an early step of the HIV-1 life cycle. Aids. 2018;30(17):2611–2616.
   Web of Science ®Google Scholar
• Yong QIU, Jing MA, Yi Z, et al. Therapeutic potential of anti-HIV RNA-loaded exosomes. Biomed Environ Sci. [Internet]. The Editorial Board of Biomedical and Environmental Sciences. 2018;31(3):215–226. Available from.
   PubMed Web of Science ®Google Scholar
• Abraham A, Krasnodembskaya A. Mesenchymal stem cell-derived extracellular vesicles for the treatment of acute respiratory distress syndrome : concise Review. Stem Cells Transl Med. 2019;9(1):28–38.
   PubMed Web of Science ®Google Scholar
• Worthington EN, Hagood JS. Therapeutic use of extracellular vesicles for acute and chronic lung disease. Int J Mol Sci. 2020;21(7):2318.
   Web of Science ®Google Scholar
• Liu J, Chen T, Lei P, et al. Exosomes released by bone marrow mesenchymal stem cells attenuate lung injury induced by intestinal ischemia reperfusion via the TLR4/NF- κ B pathway. Int J Med Sci. 2019;16(9):1238–1244.
   PubMed Web of Science ®Google Scholar
• Xu N, Shao Y, Ye K, et al. Mesenchymal stem cell-derived exosomes attenuate phosgene-induced acute lung injury in rats. Inhal Toxicol. [Internet]. Taylor & Francis. 2019;31(2):52–60. Available from.
   PubMed Web of Science ®Google Scholar
• Li Q, Liang Y, Su Z. Prophylactic treatment with MSC-derived exosomes attenuates traumatic acute lung injury in rats. 2019;316(6):L1107–L1117.
   Google Scholar
• Alipoor SD, Mortaz E. Exosomes in respiratory disease. Exosomes. [Internet]. Academic Press. 2020:383–414. Available from. DOI:https://doi.org/10.1016/B978-0-12-816053-4.00017-1.
   Google Scholar
• Yi X, Wei X, Lv H, et al. Exosomes derived from microRNA-30b-3p-overexpressing mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting SAA3. Exp Cell Res. [ [Internet]. Elsevier Inc]. 2019;383(2):111454. Available from.
   PubMed Web of Science ®Google Scholar
• Nikfarjam S, Rezaie J, Zolbanin NM, et al. Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine. J Transl Med. 2020;18(1):449.
   PubMed Web of Science ®Google Scholar
• Sengupta V, Sengupta S, Lazo A, et al. Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19. Stem Cells Dev. 2020;29(12):747–754.
   PubMed Web of Science ®Google Scholar
• Sengupta V, Sengupta S, Lazo A, et al. Response to Lim et al. re: “exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19”. Stem Cells Dev. 2020;29(14):879–881.
   PubMed Web of Science ®Google Scholar
• Weiss DJ, Lim SK, Rohde E, et al. Weiss response to Sengupta et al. Stem Cells Dev. 2020;29(24):1533–1534.
   PubMed Web of Science ®Google Scholar
• Akbari A, Rezaie J. Potential therapeutic application of mesenchymal stem cell-derived exosomes in SARS-CoV-2 pneumonia. Stem Cell Res Ther. 2020;11(1):356.
   PubMed Web of Science ®Google Scholar
• Rahimkhoei V, Rezaie J, Akbari A, et al. Nano-based methods for novel coronavirus 2019 (2019-nCoV) diagnosis: a review. Cell Biochem Funct. 2021;39(1):29–34.
   PubMed Web of Science ®Google Scholar
• Gupta A, Maffulli N, Rodriguez HC, et al. Umbilical cord-derived Wharton’s jelly for treatment of knee osteoarthritis: study protocol for a non-randomized. open-label, multi-center trial. J Orthop Surg Res. 2021;16(1):143.
   PubMed Web of Science ®Google Scholar
• Main BJ, Valk JA, Maffulli N, et al. Umbilical cord-derived Wharton's jelly for regenerative medicine applications in orthopaedic surgery: a systematic review protocol. J Orthop Surg Res. 2020;15(1):527.
   PubMed Web of Science ®Google Scholar
• Kordelas L, Rebmann V, Ludwig AK, et al. MSC-derived exosomes : a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia. 2014;28(4):970–973.
   PubMed Web of Science ®Google Scholar
• Nassar W, El-ansary M, Sabry D, et al. Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomater Res. [ [Internet]]. 2016;20(1):1–11. Available from.
   PubMedGoogle Scholar
• Vallabhaneni KC, Penfornis P, Dhule S, et al. Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites. Oncotarget. 2015;6(7):4953–4967.
   PubMedGoogle Scholar
• Rodriguez HC, Gupta M, Cavazos-Escobar E, et al. Mesenchymal stem cells and extracellular vesicles: an emerging alternative to combat COVID-19 [online first]. IntechOpen. 2021. DOI:https://doi.org/10.5772/intechopen.97212
   Google Scholar
• Diomede F, Gugliandolo A, Cardelli P, et al. Three-dimensional printed PLA scaffold and human gingival stem cell-derived extracellular vesicles : a new tool for bone defect repair. Stem Cell Res Ther. 2018;9(1):104.
   PubMedGoogle Scholar
• Mardpour S, Ghanian MH, Sadeghi-Abandansari S, et al. Hydrogel-mediated sustained systemic delivery of mesenchymal stem cell-derived extracellular vesicles improves hepatic regeneration in chronic liver failure. ACS Appl Mater Interfaces. 2019;11(41):37421–37433.
   PubMed Web of Science ®Google Scholar
• Maffulli N, Rodriguez HC, Stone IW, et al. Artificial intelligence and machine learning in orthopedic surgery: a systematic review protocol. J Orthop Surg Res. 2020;15(1):478.
   PubMed Web of Science ®Google Scholar
• Chen P, Zheng L, Wang Y, et al. Desktop-stereolithography 3D printing of a radially oriented extracellular matrix/mesenchymal stem cell exosome bioink for osteochondral defect regeneration. Theranostics. 2019;9(9):2439–2459.
   PubMed Web of Science ®Google Scholar